The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Variation of Breast Cancer Risk Among BRCA1/2 Carriers
Open accessAbstract
CONTEXT: The risk of breast cancer in BRCA1 and BRCA2 mutation carriers has been examined in many studies, but relatively little attention has been paid to the degree to which the risk may vary among carriers. OBJECTIVES: To determine the extent to which risks for BRCA1 and BRCA2 carriers vary with respect to observable and unobservable characteristics. DESIGN, SETTING, AND PARTICIPANTS: Probands were identified from a population-based, case-control study (Women's Environmental Cancer and Radiation Epidemiology [WECARE]) of asynchronous contralateral breast cancer conducted during the period of January 2000 to July 2004. Participants previously diagnosed with contralateral breast cancer or unilateral breast cancer were genotyped for mutations in BRCA1 and BRCA2. All participants had their initial breast cancer diagnosed during the period of January 1985 to December 2000, before the age of 55 years. MAIN OUTCOME MEASURE: Incidence of breast cancer in first-degree female relatives of the probands was examined and compared on the basis of proband characteristics and on the basis of variation between families. RESULTS: Among the 1394 participants with unilateral breast cancer, 73 (5.2%) were identified as carriers of deleterious mutations (42 with BRCA1 and 31 with BRCA2). Among the 704 participants with contralateral breast cancer, 108 (15.3%) were identified as carriers of deleterious mutations (67 with BRCA1 and 41 with BRCA2). Among relatives of carriers, risk was significantly associated with younger age at diagnosis in the proband (P = .04), and there was a trend toward higher risk for relatives of contralateral breast cancer vs unilateral breast cancer participants (odds ratio, 1.4 [95% confidence interval, 0.8-2.4]; P = .28). In addition, there were significant differences in risk between carrier families after adjusting for these observed characteristics. CONCLUSION: There exists broad variation in breast cancer risk among carriers of BRCA1 and BRCA2 mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Self-citationGenome-wide association study identifies novel breast cancer susceptibility loci
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature · doi:10.1038/nature05887 · Cited by 2,319
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802 · cited 1×
“2) [23-55] 45.”
Hunter, D. J., Kraft, P., Jacobs, K. B., Cox, D. G., Yeager, M., Hankinson, S. E., Wacholder, S., Wang, Z., Welch, R., Hutchinson, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2075 · Cited by 1,481
The CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Kwan, E., Jack, E., Vesprini, D. J., Kuperstein, G., Abrahamson, J. L. A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318787 · Cited by 986
Polygenic susceptibility to breast cancer and implications for prevention
Pharoah, P. D. P., Antoniou, A., Bobrow, M., Zimmern, R. L., Easton, D. F., & Ponder, B. A. J. (2002) · Nature Genetics · doi:10.1038/ng853 · Cited by 899
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Fan, I., Tang, J., Li, S., Zhang, S., Shaw, P. A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj465 · Cited by 680
Family history and the risk of breast cancer: A systematic review and meta-analysis
Pharoah, P. D. P., Day, N. E., Duffy, S., Easton, D. F., & Ponder, B. A. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970529)71:5<800::aid-ijc18>3.0.co;2-b · Cited by 651
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1407 · Cited by 604
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Stratton, M. R., Peto, J., Ponder, B. J., & Easton, D. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600008 · Cited by 495
Warner, E., Foulkes, W., Goodwin, P., Meschino, W., Blondal, J., Paterson, C., Ozcelik, H., Goss, P., Allingham-Hawkins, D., Hamel, N., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.14.1241 · Cited by 390
Population-based study of risk of breast cancer in carriers of BRCA2 mutation
Thorlacius, S., Struewing, J. P., Hartage, P., Olafsdottir, G. H., Sigvaldason, H., Tryggvadottir, L., Wacholder, S., Tulinius, H., & Eyfjörd, J. E. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03300-5 · Cited by 348
Models of genetic susceptibility to breast cancer
Antoniou, A. C., & Easton, D. F. (2006) · Oncogene · doi:10.1038/sj.onc.1209879 · Cited by 303
Statistical Methods in Genetic Epidemiology
Thomas, D. C. (2004) · doi:10.1093/oso/9780195159394.001.0001 · Cited by 284
Self-citationFollow-up study of twenty-four families with Li-Fraumeni syndrome.
Garber, J. E., Goldstein, A. M., Kantor, A. F., Dreyfus, M., Fraumeni, J. F., & Li, F. P. (1991) · PubMed · Cited by 275
Hopper, J. L., Southey, M. C., Dite, G. S., Jolley, D. J., Giles, G. G., McCredie, M. R. E., Easton, D. F., & Venter, D. J. (1999) · PubMed · Cited by 260
Validation of family history data in cancer family registries
Ziogas, A., & Anton-Culver, H. (2003) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(02)00593-7 · Cited by 240
Self-citationAndrieu, N., Goldgar, D. E., Easton, D. F., Rookus, M., Brohet, R., Antoniou, A. C., Peock, S., Evans, G., Eccles, D., Douglas, F., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj132 · Cited by 231
ATM and breast cancer susceptibility
Ahmed, M., & Rahman, N. (2006) · Oncogene · doi:10.1038/sj.onc.1209873 · Cited by 216
KHOURY, M. J., BEATY, T. H., & KUNG-YEE, L. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114842 · Cited by 213
On the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance
Begg, C. B. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.16.1221 · Cited by 201
Self-citationRisk set sampling in epidemiologic cohort studies
Goldstein, L., & Langholz, B. (1996) · Statistical Science · doi:10.1214/ss/1032209663 · Cited by 197
Self-citationRisk models for familial ovarian and breast cancer
Antoniou, A. C., Gayther, S. A., Stratton, J. F., Ponder, B. A. J., & Easton, D. F. (2000) · Genetic Epidemiology · Cited by 192
Variation in BRCA1 cancer risks by mutation position.
Thompson, D. J., & Easton, D. F. (2002) · PubMed · Cited by 187
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers
Cullinane, C. A., Lubinski, J., Neuhausen, S. L., Ghadirian, P., Lynch, H. T., Isaacs, C., Weber, B., Moller, P., Offit, K., Kim‐Sing, C., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21273 · Cited by 176
Mammographic Density and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Mitchell, G., Antoniou, A. C., Warren, R. M. L., Peock, S., Brown, J. D., Davies, R., Mattison, J., Cook, M., Warsi, I., Evans, D. G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3368 · Cited by 134
Bernstein, J. L., Langholz, B. M., Haile, R. W., Bernstein, L., Thomas, D. C., Stovall, M. A., Malone, K. E., Lynch, C. F., Olsen, J. H., Anton‐Culver, H., et al. (2004) · Breast Cancer Research · doi:10.1186/bcr771 · Cited by 128
Self-citationParity and breast cancer risk among BRCA1 and BRCA2mutation carriers
Antoniou, A. C., Shenton, A., Maher, E. R., Watson, E., Woodward, E. R., Lalloo, F. I., Easton, D. F., & Evans, D. G. (2006) · Breast Cancer Research · doi:10.1186/bcr1630 · Cited by 107
Memorial Sloan-kettering Cancer Center
Colditz, G. A. (2007) · Sage eBooks · doi:10.4135/9781412953979.n401 · Cited by 96
A Marginal Likelihood Approach for Estimating Penetrance from Kin‐Cohort Designs
Chatterjee, N., & Wacholder, S. (2001) · Biometrics · doi:10.1111/j.0006-341x.2001.00245.x · Cited by 61
Bernstein, J. L., Teraoka, S. N., Haile, R. W., Børresen‐Dale, A., Rosenstein, B. S., Gatti, R. A., Diep, A. T., Jansen, L., Atencio, D. P., Olsen, J. H., et al. (2003) · Human Mutation · doi:10.1002/humu.10206 · Cited by 60
Self-citationPolygenic Inherited Predisposition to Breast CancerPreprint
Ponder, B. A. J., Antoniou, A. C., Dunning, A. M., Easton, D. F., & Pharoah, P. D. P. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.029 · Cited by 31
Cited by
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K.-A., Mooij, T. M., Roos-Blom, M.-J., Jervis, S., van Leeuwen, F. E., Milne, R. L., Andrieu, N., et al. (2017) · JAMA · doi:10.1001/jama.2017.7112 · Cited by 2,954
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Mavaddat, N., Peock, S., Frost, D., Ellis, S., Platte, R., Fineberg, E., Evans, D. G., Izatt, L., Eeles, R. A., Adlard, J., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt095 · Cited by 951
Breast-Cancer Risk in Families with Mutations in PALB2
Antoniou, A. C., Casadei, S., Heikkinen, T., Barrowdale, D., Pylkäs, K., Roberts, J., Lee, A., Subramanian, D., De Leeneer, K., Fostira, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400382 · Cited by 851
Self-citationPathogenesis, treatment, and prevention of pneumococcal pneumonia
van der Poll, T., & Opal, S. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61114-4 · Cited by 720
Tung, N., Lin, N. U., Kidd, J., Allen, B. A., Singh, N., Wenstrup, R. J., Hartman, A.-R., Winer, E. P., & Garber, J. E. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.0747 · Cited by 556
Metadata
- Authors
- Begg, C. B., Haile, R. W., Borg, Å., Malone, K. E., Concannon, P., Thomas, D. C., Langholz, B., Bernstein, L., Olsen, J. H., Lynch, C. F., Anton-Culver, H., Capanu, M., Liang, X., Hummer, A. J., Sima, C., & Bernstein, J. L.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2008-01-09
- Volume
- 299
- Issue
- 2
- Pages
- 194-201
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2142146386
- Cited by
- 279
- References
- 34
- FWCI
- 17.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.